Hrt Financial LP Recursion Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$4.56 - $9.94 $711,647 - $1.55 Million
-156,063 Reduced 92.69%
12,314 $91,000
Q1 2023

May 12, 2023
BUY
$6.42 - $9.64 $1.08 Million - $1.62 Million
168,377 New
168,377 $1.12 Million
Q2 2022

Aug 12, 2022
SELL
$5.04 - $9.26 $268,148 - $492,669
-53,204 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.16 - $18.03 $327,736 - $959,268
53,204 New
53,204 $380,000

Others Institutions Holding RXRX

# of Institutions
289
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.18B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email